USD 0.75
(-9.64%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 4.39 Million USD | -0.96% |
2023 | 4.43 Million USD | 254.55% |
2022 | 1.25 Million USD | 471.82% |
2021 | -336.43 Thousand USD | 97.57% |
2020 | -13.84 Million USD | -130.46% |
2019 | 45.44 Million USD | 31.46% |
2018 | 34.56 Million USD | 3703.34% |
2017 | -959.34 Thousand USD | -2128.34% |
2016 | -43.05 Thousand USD | 99.63% |
2015 | -11.6 Million USD | -7.56% |
2014 | -10.79 Million USD | -2.61% |
2013 | -10.51 Million USD | -14364.85% |
2012 | 73.73 Thousand USD | -95.0% |
2011 | 1.47 Million USD | -89.6% |
2010 | 14.18 Million USD | 24.92% |
2009 | 11.35 Million USD | -1.15% |
2008 | 11.48 Million USD | -20.29% |
2007 | 14.4 Million USD | -17.24% |
2006 | 17.4 Million USD | 1.83% |
2005 | 17.09 Million USD | 638.35% |
2004 | 2.31 Million USD | 82.29% |
2003 | 1.27 Million USD | 351.39% |
2002 | 281.35 Thousand USD | -84.27% |
2001 | 1.78 Million USD | -66.79% |
2000 | 5.38 Million USD | 156.39% |
1999 | 2.1 Million USD | 5.0% |
1998 | 2 Million USD | 66.67% |
1997 | 1.2 Million USD | 5900.0% |
1996 | 20 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 1.93 Million USD | 16.42% |
2024 Q4 | 180.09 Thousand USD | 303.74% |
2024 Q3 | -171.78 Thousand USD | -109.73% |
2024 Q2 | 1.76 Million USD | -8.49% |
2023 FY | 4.43 Million USD | 254.55% |
2023 Q3 | 1.06 Million USD | 14.95% |
2023 Q2 | 927.7 Thousand USD | 18.46% |
2023 Q1 | 783.15 Thousand USD | 14.63% |
2023 Q4 | 1.65 Million USD | 55.46% |
2022 FY | 1.25 Million USD | 471.82% |
2022 Q1 | 105.54 Thousand USD | -23.18% |
2022 Q2 | 292.96 Thousand USD | 177.57% |
2022 Q3 | 169.18 Thousand USD | -42.25% |
2022 Q4 | 683.22 Thousand USD | 303.82% |
2021 Q1 | -313.76 Thousand USD | 92.44% |
2021 FY | -336.43 Thousand USD | 97.57% |
2021 Q2 | -193.37 Thousand USD | 38.37% |
2021 Q3 | 33.3 Thousand USD | 117.22% |
2021 Q4 | 137.39 Thousand USD | 312.58% |
2020 Q3 | -3.54 Million USD | -9.48% |
2020 Q1 | -3.03 Million USD | -105.42% |
2020 Q2 | -3.23 Million USD | -6.83% |
2020 Q4 | -4.14 Million USD | -17.06% |
2020 FY | -13.84 Million USD | -130.46% |
2019 Q2 | -2.96 Million USD | 17.46% |
2019 Q1 | -3.58 Million USD | -123.41% |
2019 Q3 | -3.9 Million USD | -32.0% |
2019 Q4 | 55.93 Million USD | 1530.81% |
2019 FY | 45.44 Million USD | 31.46% |
2018 Q2 | 4.56 Million USD | -64.27% |
2018 Q1 | 12.77 Million USD | -23.21% |
2018 FY | 34.56 Million USD | 3703.34% |
2018 Q3 | 1.89 Million USD | -58.53% |
2018 Q4 | 15.33 Million USD | 709.46% |
2017 Q3 | 1.76 Million USD | 121.65% |
2017 Q4 | 16.63 Million USD | 844.68% |
2017 FY | -959.34 Thousand USD | -2128.34% |
2017 Q2 | -8.13 Million USD | -1921.84% |
2017 Q1 | -402.33 Thousand USD | 96.18% |
2016 Q3 | -10.67 Million USD | 5.29% |
2016 Q4 | -10.52 Million USD | 1.42% |
2016 FY | -43.05 Thousand USD | 99.63% |
2016 Q2 | -11.27 Million USD | -6.37% |
2016 Q1 | -10.59 Million USD | 61.68% |
2015 Q4 | -27.65 Million USD | -941.3% |
2015 Q2 | 3.74 Million USD | 86.51% |
2015 FY | -11.6 Million USD | -7.56% |
2015 Q3 | -2.65 Million USD | -170.91% |
2015 Q1 | 2 Million USD | 178.38% |
2014 Q3 | -2.15 Million USD | 18.22% |
2014 Q2 | -2.63 Million USD | 23.74% |
2014 Q1 | -3.44 Million USD | 55.48% |
2014 FY | -10.79 Million USD | -2.61% |
2014 Q4 | -2.56 Million USD | -19.1% |
2013 Q3 | -2.94 Million USD | -20.56% |
2013 Q4 | -7.74 Million USD | -163.46% |
2013 FY | -10.51 Million USD | -14364.85% |
2013 Q1 | -2.33 Million USD | -21308.48% |
2013 Q2 | -2.43 Million USD | -4.26% |
2012 FY | 73.73 Thousand USD | -95.0% |
2012 Q4 | 11.03 Thousand USD | -54.03% |
2012 Q3 | 23.99 Thousand USD | 108.81% |
2012 Q2 | 11.49 Thousand USD | -57.78% |
2012 Q1 | 27.21 Thousand USD | -82.54% |
2011 FY | 1.47 Million USD | -89.6% |
2011 Q4 | 155.84 Thousand USD | 154.25% |
2011 Q3 | 61.29 Thousand USD | -94.12% |
2011 Q2 | 1.04 Million USD | 382.16% |
2011 Q1 | 216.14 Thousand USD | -67.98% |
2010 Q4 | 674.95 Thousand USD | -73.63% |
2010 Q2 | 7.28 Million USD | 98.85% |
2010 Q1 | 3.66 Million USD | -13.35% |
2010 FY | 14.18 Million USD | 24.92% |
2010 Q3 | 2.55 Million USD | -64.85% |
2009 FY | 11.35 Million USD | -1.15% |
2009 Q2 | 1.21 Million USD | 60.7% |
2009 Q3 | 5.15 Million USD | 325.91% |
2009 Q4 | 4.22 Million USD | -18.07% |
2009 Q1 | 753.84 Thousand USD | -25.79% |
2008 FY | 11.48 Million USD | -20.29% |
2008 Q1 | 8.97 Million USD | 204.55% |
2008 Q2 | 742.83 Thousand USD | -91.73% |
2008 Q3 | 746.95 Thousand USD | 0.55% |
2008 Q4 | 1.01 Million USD | 35.99% |
2007 Q1 | 4.93 Million USD | 100.24% |
2007 FY | 14.4 Million USD | -17.24% |
2007 Q3 | 3.09 Million USD | 141.3% |
2007 Q2 | -7.48 Million USD | -251.59% |
2007 Q4 | -8.58 Million USD | -377.89% |
2006 FY | 17.4 Million USD | 1.83% |
2006 Q2 | 2.54 Million USD | -50.5% |
2006 Q4 | -2.03 Billion USD | -40420.14% |
2006 Q3 | 5.04 Million USD | 98.16% |
2006 Q1 | 5.14 Million USD | -5.67% |
2005 Q1 | 4.4 Million USD | 42491.71% |
2005 Q2 | 4.59 Million USD | 4.31% |
2005 Q3 | 2.71 Million USD | -40.88% |
2005 FY | 17.09 Million USD | 638.35% |
2005 Q4 | 5.45 Million USD | 100.8% |
2004 FY | 2.31 Million USD | 82.29% |
2004 Q2 | 291.35 Thousand USD | -84.1% |
2004 Q3 | 180.75 Thousand USD | -37.96% |
2004 Q4 | 10.33 Thousand USD | -94.28% |
2004 Q1 | 1.83 Million USD | 2115.8% |
2003 Q2 | 233.5 Thousand USD | -62.55% |
2003 Q4 | 82.71 Thousand USD | -74.96% |
2003 Q3 | 330.29 Thousand USD | 41.45% |
2003 Q1 | 623.5 Thousand USD | 532.47% |
2003 FY | 1.27 Million USD | 351.39% |
2002 Q3 | 99.43 Thousand USD | 274.33% |
2002 FY | 281.35 Thousand USD | -84.27% |
2002 Q1 | -44.82 Thousand USD | -156.64% |
2002 Q2 | -57.04 Thousand USD | -27.24% |
2002 Q4 | 98.58 Thousand USD | -0.86% |
2001 FY | 1.78 Million USD | -66.79% |
2001 Q4 | 79.15 Thousand USD | -3.17% |
2001 Q3 | 81.74 Thousand USD | -90.34% |
2001 Q2 | 846.37 Thousand USD | -8.42% |
2001 Q1 | 924.2 Thousand USD | 1187.88% |
2000 Q4 | -84.95 Thousand USD | -105.63% |
2000 Q2 | 2.1 Million USD | 10.53% |
2000 Q3 | 1.5 Million USD | -28.12% |
2000 Q1 | 1.9 Million USD | -20.83% |
2000 FY | 5.38 Million USD | 156.39% |
1999 Q4 | 2.4 Million USD | 1100.0% |
1999 Q1 | 400 Thousand USD | -83.33% |
1999 Q2 | 900 Thousand USD | 125.0% |
1999 FY | 2.1 Million USD | 5.0% |
1999 Q3 | 200 Thousand USD | -77.78% |
1998 Q1 | 300 Thousand USD | 275.0% |
1998 FY | 2 Million USD | 66.67% |
1998 Q4 | 2.4 Million USD | 118.18% |
1998 Q2 | 100 Thousand USD | -66.67% |
1998 Q3 | 1.1 Million USD | 1000.0% |
1997 Q4 | 80 Thousand USD | -87.1% |
1997 Q1 | 20 Thousand USD | 0.0% |
1997 FY | 1.2 Million USD | 5900.0% |
1997 Q3 | 620 Thousand USD | 0.0% |
1997 Q2 | - USD | -100.0% |
1996 FY | 20 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AIM ImmunoTech Inc. | 160 Thousand USD | -2645.283% |
Ampio Pharmaceuticals, Inc. | -250 Thousand USD | 1856.981% |
Armata Pharmaceuticals, Inc. | -29.24 Million USD | 115.022% |
Actinium Pharmaceuticals, Inc. | -709 Thousand USD | 719.528% |
Azitra, Inc. | 260.45 Thousand USD | -1586.48% |
Can-Fite BioPharma Ltd. | 743 Thousand USD | -491.178% |
Chromocell Therapeutics Corporation | -2.57 Million USD | 270.289% |
Calidi Biotherapeutics, Inc. | -1.25 Million USD | 449.718% |
CEL-SCI Corporation | -3.95 Million USD | 210.967% |
iBio, Inc. | -1.02 Million USD | 528.532% |
Lineage Cell Therapeutics, Inc. | 8.27 Million USD | 46.913% |
MAIA Biotechnology, Inc. | - USD | -Infinity% |
Matinas BioPharma Holdings, Inc. | -13.39 Million USD | 132.797% |
Navidea Biopharmaceuticals, Inc. | -119.29 Thousand USD | 3782.009% |
NovaBay Pharmaceuticals, Inc. | 7.89 Million USD | 44.364% |
NanoViricides, Inc. | -759.01 Thousand USD | 678.705% |
Oragenics, Inc. | -15.45 Million USD | 128.425% |
BiomX Inc. | -1.22 Million USD | 457.692% |
BiomX Inc. | -1.22 Million USD | 457.692% |
Protalix BioTherapeutics, Inc. | 42.51 Million USD | 89.668% |
Scorpius Holdings, Inc. | -2.21 Million USD | 298.178% |